Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Resectable disease"'
Autor:
Xinsheng Zhu, Liangdong Sun, Nan Song, Wenxin He, Boxiong Xie, Junjie Hu, Jing Zhang, Jie Yang, Jie Dai, Dongliang Bian, Haoran Xia, Fenghuan Sun, Anwen Xiong, Jie Luo, Lele Zhang, Huansha Yu, Ming Liu, Hongcheng Liu, Haifeng Wang, Haiping Zhang, Chang Chen, Chunyan Wu, Liang Duan, Yuming Zhu, Peng Zhang, Gening Jiang
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-15 (2022)
Abstract Background This trial aimed to analyse the safety, effectiveness and transcriptomic characteristics of neoadjuvant toripalimab plus chemotherapy in II–III non-small-cell lung cancer (NSCLC). Methods Patient eligibility mainly involved trea
Externí odkaz:
https://doaj.org/article/be4ff59fe79c46a68cf6410a5d5244c2
Autor:
Fawaz A, Abdel-Rahman O
Publikováno v:
Cancer Management and Research, Vol Volume 14, Pp 3589-3598 (2022)
Ali Fawaz, Omar Abdel-Rahman Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, CanadaCorrespondence: Omar Abdel-Rahman, Department of Oncology, University of Alberta, Cross, Cancer Institute, Edmonton, Alberta,
Externí odkaz:
https://doaj.org/article/40031e6c828345818b7d53b04ede4a57
Autor:
González-Borja, Iranzu, Viúdez, Antonio, Alors-Pérez, Emilia, Goñi, Saioa, Amat, Irene, Ghanem, Ismael, Pazo-Cid, Roberto, Feliu, Jaimen, Alonso, Laura, López López, Carlos, Arrazubi, Virginia, Gallego, Javier, Pérez-Sanz, Jairo, Hernández-García, Irene, Vera, Ruth, Castaño, Justo P., Fernández-Irigoyen, Joaquín
Publikováno v:
Cancers, 2022, 14, 5993
Cancers; Volume 14; Issue 23; Pages: 5993
Cancers; Volume 14; Issue 23; Pages: 5993
Despite its relative low incidence, PDAC is one of the most aggressive and lethal types of cancer, being currently the seventh leading cause of cancer death worldwide, with a 5-year survival rate of 10.8%. Taking into consideration the necessity to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b41285a4ca6b75a0bc87ddf2134ff40
https://hdl.handle.net/10902/27860
https://hdl.handle.net/10902/27860
Autor:
M. Cambray, G. Soler, J. Castellvi, J González-Viguera, J Maria Mullerat, Ferran Losa, R Frago, E Guinó, M. Macia
Publikováno v:
Clinical and Translational Oncology. 23:2482-2488
Stage IV rectal cancer with resectable disease presents challenging issues, as the radical treatment of the whole disease is difficult. Surgery and chemotherapy (CT) play an unquestionable role, but the contribution of pelvic radiotherapy (RT) is not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b930da4579c24dea745dc08309e17b23
https://doi.org/10.1007/s12094-021-02647-0
https://doi.org/10.1007/s12094-021-02647-0
Autor:
Lorena Martin Roman, Jose Manuel Asencio Pascual, Pilar García-Alfonso, Alvaro Gregorio Morales Taboada, Jose Antonio Blanco Rodriguez, Pablo Lozano Lominchar, Andres J. Muñoz Martín
Publikováno v:
Annals of Hepato-Biliary-Pancreatic Surgery
In the last two decades, pancreatic cancer has been undergoing important changes in its perioperative management due to the great interest in multidisciplinary management and preoperative multimodal therapy, which in numerous studies have shown promi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b20a4fb8504ab9023739ba5ba5ce19c3
https://doi.org/10.14701/ahbps.2021.25.2.179
https://doi.org/10.14701/ahbps.2021.25.2.179
Autor:
Elena Rangelova
Publikováno v:
J Gastrointest Oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68a871e4b1e9333e5527dc0b607472ef
https://doi.org/10.21037/jgo-21-542
https://doi.org/10.21037/jgo-21-542
Autor:
Barbara Galassi, Maria Picchio, Paola Mapelli, Virginia Ceccarossi, Marta Vuozzo, Daniele Dondossola, Lucio Caccamo, Michele Ghidini
Publikováno v:
Cancers
Cancers, Vol 13, Iss 4155, p 4155 (2021)
Cancers, Vol 13, Iss 4155, p 4155 (2021)
Simple Summary Pancreatic cancer (PC) has a severe prognosis and even after radical surgery, relapse rate is very high (70–80%). The impact of PET/CT in PC clinical management has been increasingly investigated in the last decades. As regards local
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::518baf8dff9fa2f793a758e7ee31aee2
https://pubmed.ncbi.nlm.nih.gov/34439307
https://pubmed.ncbi.nlm.nih.gov/34439307
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Junichi Nishimura, Kazuyoshi Yamamoto, Masayuki Ohue, Naoki Shinno, Keijiro Sugimura, Takeshi Omori, Masayoshi Yasui, Naotsugu Haraguchi, Masato Sakon, Shinichiro Hasegawa, Masahiko Yano, Kei Asukai, Daisaku Yamada, Hidenori Takahashi, Hisashi Hara, Hajime Ushigome, Osamu Ishikawa, Hiroshi Miyata, Hiroshi Wada
Publikováno v:
Pancreatology. 20:919-928
Background Biological factors are emphasized in borderline resectable pancreatic cancer (BRPC), and CA19-9 is an important factor for biological borderline resectability (b-BR). The aim of this study was to investigate the cut-off value of CA19-9 for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4b7a88e26a531d1646ece4a3707e127
https://doi.org/10.1016/j.pan.2020.05.020
https://doi.org/10.1016/j.pan.2020.05.020